Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
19,25 USD | +1,91% | +6,59% | +88,91% |
Omzet 2024 * | 1,81 mln. 1,68 mln. | Omzet 2025 * | 13,23 mln. 12,33 mln. | Marktkapitalisatie | 829 mln. 773 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -171 mln. -159 mln. | Nettowinst (verlies) 2025 * | -178 mln. -166 mln. | EV/omzet 2024 * | 219 x |
Nettoliquiditeiten 2024 * | 433 mln. 404 mln. | Nettoliquiditeiten 2025 * | 427 mln. 398 mln. | EV/omzet 2025 * | 30,4 x |
K/w-verhouding 2024 * |
-5,64
x | K/w-verhouding 2025 * |
-6,27
x | Werknemers | 85 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 93,6% |
Recentste transcriptie over Cullinan Therapeutics, Inc.
1 dag | +1,91% | ||
1 week | +6,59% | ||
Lopende maand | +12,97% | ||
1 maand | +13,70% | ||
3 maanden | +48,08% | ||
6 maanden | +125,94% | ||
Lopend jaar | +88,91% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 18-10-21 |
Jeffrey Jones
CTO | Chief Tech/Sci/R&D Officer | 53 | 28-02-22 |
Jacquelyn Sumer
CMP | Compliance Officer | 46 | 15-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 71 | 01-08-17 | |
Thomas Ebeling
BRD | Director/Board Member | 65 | 01-08-17 |
Stephen Webster
BRD | Director/Board Member | 63 | 01-09-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.04% | 0 M€ | 0,00% | - | |
0.03% | 0 M€ | 0,00% | - | |
0.03% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 19,25 | +1,91% | 1 289 236 |
24-04-24 | 18,89 | +13,32% | 1 173 778 |
23-04-24 | 16,67 | +6,65% | 966 393 |
22-04-24 | 15,63 | -0,19% | 968 160 |
19-04-24 | 15,66 | -13,29% | 1 179 332 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+88,91% | 814 mln. | |
+1,12% | 43,84 mld. | |
+6,77% | 41,68 mld. | |
+45,26% | 41,25 mld. | |
-11,96% | 27,04 mld. | |
+6,01% | 25,53 mld. | |
-24,92% | 18,18 mld. | |
-3,63% | 12,29 mld. | |
+27,16% | 12,29 mld. | |
+7,30% | 11,15 mld. |